Dishman Carbogen Amcis Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
May 30, 2024 at 02:15 pm EDT
Share
Dishman Carbogen Amcis Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 6,547.1 million compared to INR 6,185.6 million a year ago. Revenue was INR 6,618.7 million compared to INR 6,253.1 million a year ago. Net loss was INR 699.2 million compared to INR 707.2 million a year ago. Basic loss per share from continuing operations was INR 4.46 compared to INR 4.51 a year ago. Diluted loss per share from continuing operations was INR 4.46 compared to INR 4.51 a year ago.
For the full year, sales was INR 26,157.7 million compared to INR 24,129.2 million a year ago. Revenue was INR 26,439.8 million compared to INR 24,406.9 million a year ago. Net loss was INR 1,534.5 million compared to INR 298 million a year ago. Basic loss per share from continuing operations was INR 9.79 compared to INR 1.9 a year ago. Diluted loss per share from continuing operations was INR 9.79 compared to INR 1.9 a year ago.
Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS), quats, specialty chemicals, Vitamins D3 and its analogues, cholesterols, and disinfectants. The Companyâs segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. Its Marketable Molecules segment manufactures and supplies intermediates, chemicals, and various products for pharmaceutical, cosmetic and related industries. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd. and Dishman Carbogen Amcis (Singapore) Pte. Ltd.